1-12825017-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001146344.3(PRAMEF11):āc.1362G>Cā(p.Leu454Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,609,828 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001146344.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000860 AC: 13AN: 151100Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250194Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135398
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1458616Hom.: 2 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 725516
GnomAD4 genome AF: 0.0000926 AC: 14AN: 151212Hom.: 0 Cov.: 27 AF XY: 0.0000949 AC XY: 7AN XY: 73798
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | The c.1236G>C (p.L412F) alteration is located in exon 4 (coding exon 3) of the PRAMEF11 gene. This alteration results from a G to C substitution at nucleotide position 1236, causing the leucine (L) at amino acid position 412 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at